Why Fund Managers Are Betting Big on Healthcare REITs: Neo Ivy's Timely Investment Amid Market Surge

Healthcare real estate investment trusts (REITs) are capturing institutional attention like never before. In February 2026, Neo Ivy Capital Management made a strategic move that underscores this trend—acquiring 136,925 shares of American Healthcare REIT (NYSE: AHR) in a transaction valued at approximately $6.44 million. While this 1.02% position may seem modest relative to the fund’s total assets under management, it signals something more significant: investors are increasingly recognizing the structural opportunities embedded in healthcare REIT portfolios.

The timing of this purchase is noteworthy. American Healthcare REIT shares have climbed 93.3% over the past year, with the stock trading at $51.70 as of mid-February 2026. Yet the rally isn’t merely speculative. Behind the surge lies a compelling fundamental story rooted in demographic shifts and operational excellence.

Healthcare REIT Portfolio Attracts Institutional Capital as Demographic Demand Strengthens

The appeal of healthcare REITs extends beyond attractive stock price momentum. These vehicles provide institutional investors with exposure to a resilient, growth-oriented real estate segment. American Healthcare REIT operates a diversified portfolio spanning medical office buildings, senior housing communities, skilled nursing facilities, and integrated senior health campuses across the U.S. and United Kingdom. The company generates consistent cash flows through long-term leases and professional asset management, benefiting from scale efficiencies and a fully integrated operational platform.

For fund managers evaluating allocation strategies, healthcare REITs offer several advantages. Unlike traditional commercial real estate—vulnerable to remote work trends and economic cycles—healthcare facilities face structural demand tailwinds. An aging population translates to sustained occupancy pressure in senior housing and higher utilization rates for medical office space. Neo Ivy’s positioning within this REIT category reflects a calculated bet on these secular dynamics rather than a short-term momentum trade.

Strong Q3 Performance and Rising Occupancy Drive REIT Investment Appetite

The numbers validate the thesis. In the third quarter of 2025, American Healthcare REIT delivered 16.4% same-store NOI (net operating income) growth—a substantial increase that underscores operational momentum. Breaking this down, senior housing operating properties surged 25.3%, while integrated senior health campuses expanded 21.7%. These gains far exceed inflation-driven expectations.

The company reported GAAP net income of $55.9 million, or $0.33 per diluted share, while normalized funds from operations (FFO) reached $0.44 per share. Management subsequently raised full-year normalized FFO guidance to a range of $1.69–$1.72, signaling confidence in sustained execution. Equally important, the firm lifted total portfolio same-store NOI growth expectations to as high as 15%—a level that attracts yield-focused institutional capital seeking both income and capital appreciation.

These metrics reflect more than cyclical strength. Occupancy rates above 90% in senior housing communities indicate that demographic demand is translating into tangible operational results. For Neo Ivy Capital Management, allocating 1.02% of its REIT portfolio to American Healthcare at this juncture represents a measured exposure to this momentum without over-concentrating risk. The fund’s broader holdings—including positions in industrials, consumer technology, and mega-cap semiconductors—suggest a diversified approach to capturing healthcare real estate upside while maintaining balanced exposure across economic cycles.

Beyond the Stock Rally: Building a Lasting REIT Investment Thesis

The stock’s 93% annual return naturally attracts attention, but institutional investors are trained to look beyond near-term appreciation. The durable REIT investment case rests on three pillars: demographic tailwinds driving occupancy gains, disciplined capital allocation by management, and efficient access to capital markets for growth-stage acquisitions.

American Healthcare REIT’s track record suggests competence across all three dimensions. The company’s dividend yield stands at 1.92%, providing a modest income cushion while preserving capital for reinvestment and growth. With a market capitalization of $9.65 billion and trailing-twelve-month revenue of $2.20 billion, the REIT operates at scale sufficient to negotiate favorable terms with operators and tenants while maintaining operational flexibility.

Sustained occupancy above 90% in senior housing—a critical metric for long-term value creation—reflects the company’s ability to select quality assets in high-demand markets. Unlike pure development plays or speculative real estate bets, healthcare REITs benefit from regulatory barriers to entry and the inelasticity of demand for senior care facilities. As populations age and healthcare facility demand accelerates, well-positioned REITs with diversified portfolios compound shareholder value through a combination of rent growth, occupancy expansion, and accretive acquisitions.

For investors evaluating whether now is the moment to establish or expand healthcare REIT exposure, the Neo Ivy transaction serves as a reminder: the best time to invest in a structural trend often arrives when the thesis is becoming widely understood, not when it remains obscure. The 93% rally has brought healthcare REITs into mainstream consciousness, yet the demographic story—and the corresponding earnings growth potential—remains in its early innings.